XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity
 3 Months Ended
Mar. 31, 2023
Shareholders' Equity  
Shareholders' Equity

7. Shareholders' Equity

 

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

Common stock and additional paid-in capital

 

 

 

 

 

 

 

 

Balance, beginning of period

 

$

74,934

 

 

$

72,818

 

Issuance of common stock and warrants, net

 —


2,000

Share-based compensation expense

 

 

22

 

 

 

35

 

Proceeds from employee stock purchase plan

 

 

1

 

 

 

2

 

Balance, end of period

 

$

74,957

 

 

$

74,855

 

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive loss

 

 

 

 

 

 

 

 

Balance, beginning of period

 

$

(288

 )

 

$

(241

)

Unrealized loss on available-for-sale securities, net of tax 

 

 

—

 

 

(28

 )

Foreign currency translation adjustment

 

 

5

 

 

(11

 )

Balance, end of period

 

$

(283

 )

 

$

(280

)

 

 

 

 

 

 

 

 

 

Accumulated deficit 

 

 

 

 

 

 

 

 

Balance, beginning of period

 

$

(516

 )

 

$

(21,072

 )

Net loss

 

 

(832

 )

 

 

(1,967

)

Balance, end of period

 

$

(1,348

 )

 

$

(23,039

)

 

 

 

 

 

 

 

 

 

Total shareholders' equity

 

$

73,326

 

 

$

51,536

 

 

Issue of Common Stock and Warrants


On  September 12, 2021, the Company entered into a securities purchase agreement with certain purchasers named therein, pursuant to which the Company issued 3,623,189 shares of the Company's common stock, par value $0.001 per share at an offering price of $2.76 per share. The Company received gross proceeds of approximately $10,000 and net proceeds of $9,288 after deducting placement agent fees and related offering expenses. In a concurring private placement the Company also issued to the same purchasers warrants exercisable for an aggregate of 3,623,189 shares of common stock at an exercise price of $2.76 per share. Each warrant became immediately exercisable and will expire on March 15, 2027.


On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, an affiliate of the Company, pursuant to which the Company agreed to issue and sell, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares is the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.